Find insight on Merck, Sanofi and more in the latest Market Talks covering the Health Care sector.

Merck cut its 2025 adjusted earnings projection to a range between $8.82 and $8.97 a share from a previous estimate of $8.88 to $9.03 a share. The new guidance includes a charge of roughly $200 ...

Selling, general and administrative expenses were $2.6 billion in the first quarter, Merck noted, an increase of 3% compared with the first quarter of 2024. The increase was primarily due to higher ...

Two new cases of polio have been confirmed in Hadejia and Suletankarkar Local Government Areas of Jigawa State, marking a ...

Participants at the Town Hall meeting organised by Lagos State with support from Gates Foundation and Pathfinder International, recently in Ikeja, Lagos.… Hosts Townhall Meeting, Urges Community ...

The First Lady, Senator Oluremi Tinubu, has donated N1 billion to the National Taskforce on Cervical Cancer Elimination in Nigeria (NTF-CCE) to fight the scourge of cervical cancer.A statement from ...

HPV vaccine recommendations. Centers for Disease Control and Prevention ... Chancroid. Ogale YP, Ridpath AD, Torrone E, Quilter LAS, Grey JA. A sore subject? An examination of national case-based ...

A steep fall in demand from China drove a 41% decline in MSD Q1 2025 sales of its human papillomavirus (HPV) vaccines Gardasil and Gardasil 9, marking a continued setback for the company’s ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between the US and China, where demand for its blockbuster Gardasil vaccine is ...